Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals

By Kappelhoff Bregt S.  

Clinical Pharmacokinetics, Vol. 44, Iss. 8, 2005-01 ,pp. : 849-861

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals

By Back David J.   Owen Andrew   Khoo Saye H.  

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 213-214

Adis International

Access to resources Recommend Favorite

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors

By Dailly Eric   Billaud Eric   Reliquet Véronique   Breurec Sébastien   Perré Philippe   Léautez Sophie   Jolliet Pascale   Bourin Michel   Raffi François  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 343-348

Springer Publishing Company

Access to resources Recommend Favorite

Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals

By de Maat M.M.R.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 629-637

Adis International

Access to resources Recommend Favorite

Hepatotoxicity Following Nevirapine-Containing Regimens in Hiv-1-Infected Individuals

By de Maat M.M.R.   Mathot R.A.A.   Veldkamp A.I.   Huitema A.D.R.   Mulder J.W.   Meenhorst P.L.   van Gorp E.C.M.   Carlier H.   Beijnen J.H.  

Pharmacological Research, Vol. 46, Iss. 3, 2002-09 ,pp. : 295-300

Academic Press

Access to resources Recommend Favorite